7 research outputs found
Strain-Dependent Differences in Bone Development, Myeloid Hyperplasia, Morbidity and Mortality in Ptpn2-Deficient Mice
Single nucleotide polymorphisms in the gene encoding the protein tyrosine phosphatase TCPTP (encoded by PTPN2) have been linked with the development of autoimmunity. Here we have used Cre/LoxP recombination to generate Ptpn2ex2β/ex2β mice with a global deficiency in TCPTP on a C57BL/6 background and compared the phenotype of these mice to Ptpn2β/β mice (BALB/c-129SJ) generated previously by homologous recombination and backcrossed onto the BALB/c background. Ptpn2ex2β/ex2β mice exhibited growth retardation and a median survival of 32 days, as compared to 21 days for Ptpn2β/β (BALB/c) mice, but the overt signs of morbidity (hunched posture, piloerection, decreased mobility and diarrhoea) evident in Ptpn2β/β (BALB/c) mice were not detected in Ptpn2ex2β/ex2β mice. At 14 days of age, bone development was delayed in Ptpn2β/β (BALB/c) mice. This was associated with increased trabecular bone mass and decreased bone remodeling, a phenotype that was not evident in Ptpn2ex2β/ex2β mice. Ptpn2ex2β/ex2β mice had defects in erythropoiesis and B cell development as evident in Ptpn2β/β (BALB/c) mice, but not splenomegaly and did not exhibit an accumulation of myeloid cells in the spleen as seen in Ptpn2β/β (BALB/c) mice. Moreover, thymic atrophy, another feature of Ptpn2β/β (BALB/c) mice, was delayed in Ptpn2ex2β/ex2β mice and preceded by an increase in thymocyte positive selection and a concomitant increase in lymph node T cells. Backcrossing Ptpn2β/β (BALB/c) mice onto the C57BL/6 background largely recapitulated the phenotype of Ptpn2ex2β/ex2β mice. Taken together these results reaffirm TCPTP's important role in lymphocyte development and indicate that the effects on morbidity, mortality, bone development and the myeloid compartment are strain-dependent
The influence of CD1d in postselection NKT cell maturation and homeostasis
C1 - Journal Articles RefereedAfter being positively selected on CD1d-expressing thymocytes, NKT cells undergo a series of developmental changes that can take place inside or outside the thymus. We asked whether CD1d continues to play a role in late-stage NKT cell development and, in particular, during the functionally significant acquisition of NK1.1 that is indicative of NKT cell maturity. We report that CD1d is indeed crucial for this step, because immature NK1.1(-) NKT cells fail to fully mature when transferred to a CD1d-deficient environment. Surprisingly, however, the lack of CD1d did not greatly affect the long-term survival of NKT cells, and they continued to express CD69 and slowly proliferate. This directly contradicts the currently held view that these phenomena are caused by autoreactivity directed against CD1d/TCR-restricted self-Ags. Our findings demonstrate an ongoing role for TCR-mediated signaling throughout NKT cell development, but the characteristic semiactivated basal state of NKT cells is controlled by CD1d-independent factors or is intrinsic to the cells themselves
IL-21 is produced by NKT cells and modulates NKT cell activation and cytokine production
IL-21 is produced by NKT cells and modulates NKT cell activation and cytokine production
IL-17-producing NKT cells depend exclusively on IL-7 for homeostasis and survival
Natural killer T (NKT) cells are innate-like T cells that rapidly recognize pathogens and produce cytokines that shape the ensuing immune response. IL-17-producing NKT cells are enriched in barrier tissues, such as the lung, skin, and peripheral lymph nodes, and the factors that maintain this population in the periphery have not been elucidated. Here we show that NKT17 cells deviate from other NKT cells in their survival requirements. In contrast to conventional NKT cells that are maintained by IL-15, RORΞ³t NKT cells are IL-15 independent and instead rely completely on IL-7. IL-7 initiates a T-cell receptor-independent (TCR-independent) expansion of NKT17 cells, thus supporting their homeostasis. Without IL-7, survival is dramatically impaired, yet residual cells remain lineage committed with no downregulation of RORΞ³t evident. Their preferential response to IL-7 does not reflect enhanced signaling through STAT proteins, but instead is modulated via the PI3K/AKT/mTOR signaling pathway. The ability to compete for IL-7 is dependent on high-density IL-7 receptor expression, which would promote uptake of low levels of IL-7 produced in the non-lymphoid sites of lung and skin. This dependence on IL-7 is also reported for RORΞ³t innate lymphoid cells and CD4 Th17 cells, and suggests common survival requirements for functionally similar cells
ZBTB7B (Th-POK) Regulates the Development of IL-17-Producing CD1d-Restricted Mouse NKT Cells
The research outputs in this collection have been funded in whole or in part by the National Health and Medical Research Council (NHMRC)Published VersionCopyright Β© 2012 by The American Association of ImmunologistsCD1d-dependent NKT cells represent a heterogeneous family of effector T cells including CD4(+)CD8(-) and CD4(-)CD8(-) subsets that respond to glycolipid Ags with rapid and potent cytokine production. NKT cell development is regulated by a unique combination of factors, however very little is known about factors that control the development of NKT subsets. In this study, we analyze a novel mouse strain (helpless) with a mis-sense mutation in the BTB-POZ domain of ZBTB7B and demonstrate that this mutation has dramatic, intrinsic effects on development of NKT cell subsets. Although NKT cell numbers are similar in Zbtb7b mutant mice, these cells are hyperproliferative and most lack CD4 and instead express CD8. Moreover, the majority of ZBTB7B mutant NKT cells in the thymus are retinoic acid-related orphan receptor Ξ³t positive, and a high frequency produce IL-17 while very few produce IFN-Ξ³ or other cytokines, sharply contrasting the profile of normal NKT cells. Mice heterozygous for the helpless mutation also have reduced numbers of CD4(+) NKT cells and increased production of IL-17 without an increase in CD8(+) cells, suggesting that ZBTB7B acts at multiple stages of NKT cell development. These results reveal ZBTB7B as a critical factor genetically predetermining the balance of effector subsets within the NKT cell population
Diverse cytokine production by NKT cell subsets and identification of an IL-17βproducing CD4βNK1.1β NKT cell population
NKT cell subsets can be divided based on CD4 and NK1.1 expression and tissue of origin, but the developmental and functional relationships between the different subsets still are poorly understood. A comprehensive study of 19 cytokines across different NKT cell subsets revealed that no two NKT subpopulations exhibited the same cytokine profile, and, remarkably, the amounts of each cytokine produced varied by up to 100-fold or more among subsets. This study also revealed the existence of a population of CD4βNK1.1β NKT cells that produce high levels of the proinflammatory cytokine IL-17 within 2β3 h of activation. On intrathymic transfer these cells develop into mature CD4βNK1.1+ but not into CD4+NK1.1+ NKT cells, indicating that CD4βNK1.1β NKT cells include an IL-17βproducing subpopulation, and also mark the elusive branch point for CD4+ and CD4β NKT cell sublineages